These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23239208)

  • 1. Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography.
    Hyafil F; Feldman L; Le Guludec D; Fayad ZA
    Mt Sinai J Med; 2012; 79(6):689-704. PubMed ID: 23239208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical imaging in anti-atherosclerosis drug development.
    Ehlgen A; Bylock A; Kreuzer J; Koslowski M; Gantner F; Niessen HG
    Drug Discov Today; 2015 Nov; 20(11):1317-27. PubMed ID: 26151479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional imaging of carotid atheromatous plaques.
    Warburton L; Gillard J
    J Neuroimaging; 2006 Oct; 16(4):293-301. PubMed ID: 17032377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.
    Girotra S; Murarka S; Migrino RQ
    Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids, biomarkers, and noninvasive imaging of atherosclerotic disease activity in clinical trials.
    McCullough PA; Lepor NE
    Rev Cardiovasc Med; 2008; 9(2):142-9. PubMed ID: 18660735
    [No Abstract]   [Full Text] [Related]  

  • 6. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
    Zhao ZM; Qin SC
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT for atherosclerotic plaque imaging.
    Ben-Haim S; Israel O
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):53-60. PubMed ID: 16557204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment.
    Saam T; Hatsukami TS; Takaya N; Chu B; Underhill H; Kerwin WS; Cai J; Ferguson MS; Yuan C
    Radiology; 2007 Jul; 244(1):64-77. PubMed ID: 17581895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of atherosclerosis: magnetic resonance imaging.
    Corti R; Fuster V
    Eur Heart J; 2011 Jul; 32(14):1709-19b. PubMed ID: 21508002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.
    Ogawa M; Magata Y; Kato T; Hatano K; Ishino S; Mukai T; Shiomi M; Ito K; Saji H
    J Nucl Med; 2006 Nov; 47(11):1845-50. PubMed ID: 17079818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in atheroma imaging in the carotid.
    Gillard JH
    Cerebrovasc Dis; 2007; 24 Suppl 1():40-8. PubMed ID: 17971638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid MRI: a tool for monitoring individual response to cardiovascular therapy?
    Underhill HR; Yuan C
    Expert Rev Cardiovasc Ther; 2011 Jan; 9(1):63-80. PubMed ID: 21166529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs.
    Charakida M; Masi S; Loukogeorgakis SP; Deanfield JE
    Curr Opin Lipidol; 2009 Dec; 20(6):460-6. PubMed ID: 19851104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of molecular imaging in drug discovery and development.
    Hargreaves RJ
    Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory drugs and atherosclerosis.
    Moubayed SP; Heinonen TM; Tardif JC
    Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of advanced cardiac imaging methods in coronary artery disease].
    Kiraç S
    Anadolu Kardiyol Derg; 2008 Jul; 8 Suppl 1():1-4. PubMed ID: 18611832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Lp-PLA2 in lipid-lowering therapy.
    Racherla S; Arora R
    Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutraceuticals and atherosclerosis: human trials.
    Badimon L; Vilahur G; Padro T
    Cardiovasc Ther; 2010 Aug; 28(4):202-15. PubMed ID: 20633023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis imaging as a benchmark in the development of novel cardiovasular drugs.
    Duivenvoorden R; Nederveen AJ; de Groot E; Kastelein JJ
    Curr Opin Lipidol; 2007 Dec; 18(6):613-21. PubMed ID: 17993805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.